Supply Chain Intelligence

Prothena Corporation plc Supply Chain

PRTA supply chain intelligence for Prothena Corporation plc: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

PRTA ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

3Suppliers
4Customers
1Debt Items
20Related Chains

Prothena Corporation plc Suppliers

TickerNameConfidenceEvidence
ROCHE ROCHE 90% We have entered into the License Agreement with Roche for the development of prasinezumab
IKT Inhibikase Therapeutics, Inc. 72% Reciprocal relationship from IKT graph: tractive; and • a product candidate may not be capable of being produced in commercial quantities at an acceptable cost, or at all; if a product candidate obta…
NOVO-NORDISK NOVO-NORDISK 60% we may enter into additional agreements in the future, and we might not realize the anticipated benefits of such agreements including receiving anticipated milestone payments pursuant to these agreements

Prothena Corporation plc Customers

TickerNameConfidenceEvidence
NOVO-NORDISK NOVO-NORDISK 90% The Company’s revenue during the three months ended March 31, 2026 was primarily from revenue from the development milestone payment received from Novo Nordisk
IKT Inhibikase Therapeutics, Inc. 72% Reciprocal relationship from IKT graph: Reciprocal relationship from PRTA graph: Reciprocal relationship from IKT graph: Reciprocal relationship from PRTA graph: Reciprocal relationship from IKT grap…
PRGO Perrigo Company plc 72% scientific and other personnel are critical to our growth and future success. Competition for qualified personnel in our industry is intense. We may not be able to attract and retain these personnel …
PRGO Perrigo Company plc 72% Reciprocal relationship from PRGO graph: Reciprocal relationship from PRTA graph: Reciprocal relationship from PRGO graph: Reciprocal relationship from PRTA graph: Reciprocal relationship from PRGO g…

Prothena Corporation plc Debt Obligations

InstrumentDescriptionConfidenceEvidence
PRTA-DEBT Debt stack $7.7M 90% Market cache reports total debt of $7.7M.

Prothena Corporation plc Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Prothena Corporation plc.

Prothena Corporation plc Ownership

HolderNameConfidenceEvidence
PRTA-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 187 tracked holders.

Prothena Corporation plc Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
CANF Can-Fite BioPharma Ltd. 100.00 2
SDGR Schrödinger, Inc. 100.00 2
ALNY Alnylam Pharmaceuticals, Inc. 100.00 2
SLGN Silgan Holdings Inc. 100.00 2
EVAX Evaxion A/S 100.00 2
HIMS Hims & Hers Health, Inc. 100.00 2
IPHA Innate Pharma S.A. 100.00 2
NONOF Novo Nordisk A/S 100.00 2
ASND Ascendis Pharma A/S 100.00 2
IKT Inhibikase Therapeutics, Inc. 100.00 1 ['customer', 'supplier']
LLY Eli Lilly and Company 100.00 2
DNLI Denali Therapeutics Inc. 50.00 2
KRRO Korro Bio, Inc. 50.00 2
IXHL Incannex Healthcare Inc. 50.00 2
GOSS Gossamer Bio, Inc. 50.00 2
LCTX Lineage Cell Therapeutics, Inc. 50.00 2
MDGL Madrigal Pharmaceuticals, Inc. 50.00 2
SNY Sanofi 50.00 2
LXRX Lexicon Pharmaceuticals, Inc. 50.00 2
View PRTA supply chain intel →

Explore the full interactive supply chain map for Prothena Corporation plc.

Open PRTA supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map